Реестр международных мультицентровых клинических исследований лекарств в России
Study List: Study 1: Title: A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Cancer|Cataract|Low Bone Mineral Density|Osteopenia|Osteoporosis|Prostate Cancer Interventions: Biological: Denosumab|Biological: Placebo URL: http://ClinicalTrials.gov/show/NCT00925600 Study 2: Title: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Intra-Abdominal Infection Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039)|Drug: Ertapenem, Amoxicillin/clavulanate URL: http://ClinicalTrials.gov/show/NCT01069900 Study 3: Title: A Study of LY2140023 in Patients With Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Drug: LY2140023|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01307800 Study 4: Title: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thrombosis Interventions: Drug: Enoxaparin|Drug: warfarin|Drug: Placebo for apixaban|Drug: Placebo for enoxaparin|Drug: Placebo for warfarin|Drug: apixaban URL: http://ClinicalTrials.gov/show/NCT00643201 Study 5: Title: LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib Recruitment: Recruiting Study Results: No Results Available Conditions: or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.|ErbB2 (HER2) Amplified Gastric|Neoplasms, Gastrointestinal Tract|Esophageal Interventions: Drug: Lapatinib|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00680901 Study 6: Title: Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Advanced Breast Cancer|Breast Cancer Interventions: Drug: Neratinib|Drug: Lapatinib|Drug: Capecitabine URL: http://ClinicalTrials.gov/show/NCT00777101 Study 7: Title: An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical or Urgent Invasive Procedure Recruitment: Recruiting Study Results: No Results Available Conditions: Reversal of Coagulopathy Interventions: Biological: Beriplex® P/N|Biological: Fresh frozen plasma URL: http://ClinicalTrials.gov/show/NCT00803101 Study 8: Title: Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Drug: Interferon β 1a|Drug: DAC HYP URL: http://ClinicalTrials.gov/show/NCT01064401 Study 9: Title: IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Renal Cell Carcinoma Interventions: Drug: Sunitinib|Biological: IMA901 plus GM-CSF|Drug: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01265901 Study 10: Title: A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: URL: http://ClinicalTrials.gov/show/NCT01394601 Study 11: Title: Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Recruitment: Recruiting Study Results: No Results Available Conditions: Cardiovascular Diseases|Heart Diseases|Heart Failure, Congestive Interventions: Drug: Aldosterone Antagonist (spironolactone)|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00094302 Study 12: Title: A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) Recruitment: Recruiting Study Results: No Results Available Conditions: Disease, Hodgkin Interventions: Drug: brentuximab vedotin|Drug: placebo URL: http://ClinicalTrials.gov/show/NCT01100502 Study 13: Title: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Seizures|Epilepsy|Partial-Onset Seizures Interventions: Drug: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01227902 Study 14: Title: A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Drug: LY2127399|Drug: Placebo every 2 weeks|Drug: Placebo every 4 weeks URL: http://ClinicalTrials.gov/show/NCT01198002 Study 15: Title: Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer Interventions: Drug: Eniluracil|Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Capecitabine URL: http://ClinicalTrials.gov/show/NCT01231802 Study 16: Title: A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Recruitment: Recruiting Study Results: No Results Available Conditions: Tumor|Pain Interventions: Drug: CG5503 ER|Drug: Placebo to match CG5503|Drug: Morphine Sulphate CR|Drug: Placebo to match Morphine Sulphate CR URL: http://ClinicalTrials.gov/show/NCT00472303 Study 17: Title: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Drug: ATN-103|Drug: ATN-103 URL: http://ClinicalTrials.gov/show/NCT01063803 Study 18: Title: A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia Recruitment: Recruiting Study Results: No Results Available Conditions: Lymphocytic Leukemia, Chronic Interventions: Drug: rituximab [MabThera]|Drug: rituximab [MabThera]|Drug: rituximab [MabThera]|Drug: Fludarabine|Drug: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01292603 Study 19: Title: A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Chronic Hepatitis B Virus, Pediatric Interventions: Drug: Entecavir|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01079806 Study 20: Title: Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Recruitment: Recruiting Study Results: No Results Available Conditions: Alopecia|Androgenetic Alopecia Interventions: Drug: 1mg Finasteride active|Drug: 0.02mg dutasteride|Drug: 0.1mg dutasteride|Drug: 0.5mg dutasteride|Drug: Finasteride placebo|Drug: Dutasteride placebo URL: http://ClinicalTrials.gov/show/NCT01231607 Study 21: Title: Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Atrial Fibrillation|Arrhythmia|Stroke Prevention|Mortality Interventions: Device: Left atrial ablation|Drug: Rate or Rhythm Control Therapy URL: http://ClinicalTrials.gov/show/NCT00911508 Study 22: Title: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes Mellitus, Type 2|Acute Coronary Syndrome Interventions: Drug: Alogliptin|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00968708 Study 23: Title: Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Drug: Placebo|Drug: Placebo|Drug: Placebo|Drug: Placebo|Drug: Placebo|Drug: 50 mcg salmeterol HFA MDI|Drug: 5 mcg tiotropium Respimat®|Drug: 2.5 mcg tiotropium Respimat® URL: http://ClinicalTrials.gov/show/NCT01172808 Study 24: Title: Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatocellular Carcinoma Interventions: Drug: sorafenib|Biological: mapatumumab URL: http://ClinicalTrials.gov/show/NCT01258608 Study 25: Title: Study Of Letrozole With Or Without PD 0332991 For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Drug: PD 0332991|Drug: letrozole|Drug: letrozole URL: http://ClinicalTrials.gov/show/NCT00721409 Study 26: Title: Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Lung Cancer - Non Small Cell Interventions: Drug: Ipilimumab|Drug: Placebo|Drug: Paclitaxel|Drug: Carboplatin URL: http://ClinicalTrials.gov/show/NCT01285609 Study 27: Title: Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Alzheimer Disease Interventions: Drug: bapineuzumab|Drug: bapineuzumab|Drug: placebo URL: http://ClinicalTrials.gov/show/NCT00667810 Study 28: Title: Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) Recruitment: Recruiting Study Results: No Results Available Conditions: B-Cell Chronic Lymphocytic Leukemia (B-CLL) Interventions: Drug: Lenalidomide|Drug: Chlorambucil URL: http://ClinicalTrials.gov/show/NCT00910910 Study 29: Title: A Study of MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status Recruitment: Recruiting Study Results: No Results Available Conditions: Lymphocytic Leukemia, Chronic Interventions: Drug: rituximab [MabThera]|Drug: fludarabine|Drug: cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01271010 Study 30: Title: A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Neoplasms, Breast Interventions: Drug: lapatinib|Drug: trastuzumab|Drug: Aromatase inhibitor|Drug: lapatinib URL: http://ClinicalTrials.gov/show/NCT01160211 Study 31: Title: A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee Recruitment: Recruiting Study Results: No Results Available Conditions: Osteoarthritis Interventions: Drug: SD-6010|Drug: SD-6010|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00565812 Study 32: Title: Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids Recruitment: Not yet recruiting Study Results: No Results Available Conditions: Asthma Interventions: Drug: Placebo matching Respimat|Drug: Placebo matching Respimat|Drug: BI 54903 MD|Drug: BI 54903 HD URL: http://ClinicalTrials.gov/show/NCT01458912 Study 33: Title: Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure Recruitment: Recruiting Study Results: No Results Available Conditions: Heart Failure Interventions: Drug: Placebo|Drug: Omecamtiv mecarbil URL: http://ClinicalTrials.gov/show/NCT01300013 Study 34: Title: Study of Immunotherapy to Treat Advanced Prostate Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: Drug: Ipilimumab|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00861614 Study 35: Title: Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Non-small Cell Lung Cancer Interventions: Drug: Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel|Drug: Placebo in combination with cisplatin and docetaxel or paclitaxel URL: http://ClinicalTrials.gov/show/NCT00966914 Study 36: Title: An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes Mellitus, Type 2|Renal Insufficiency Interventions: Drug: Canagliflozin 100 mg|Drug: Canagliflozin 300 mg|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01064414 Study 37: Title: ACT-293987 in Pulmonary Arterial Hypertension Recruitment: Recruiting Study Results: No Results Available Conditions: Pulmonary Arterial Hypertension Interventions: Drug: ACT-293987|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01106014 Study 38: Title: A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Drug: tocilizumab [RoActemra/Actemra]|Drug: tocilizumab [RoActemra/Actemra]|Drug: placebo|Drug: placebo|Drug: Disease-modifying antirheumatic drugs (DMARDs) URL: http://ClinicalTrials.gov/show/NCT01194414 Study 39: Title: Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Drug: Fostamatinib|Drug: Fostamatinib|Drug: Fostamatinib URL: http://ClinicalTrials.gov/show/NCT01242514 Study 40: Title: RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Heart Failure|Anemia|Cardiovascular Disease|Ventricular Dysfunction|Congestive Heart Failure Interventions: Drug: Darbepoetin alfa|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00358215 Study 41: Title: AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: Drug: bevacizumab [Avastin]|Drug: pemetrexed|Drug: cisplatin URL: http://ClinicalTrials.gov/show/NCT00961415 Study 42: Title: Study of ACT-129968 in Adult Patients With Partly Controlled Asthma. Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Drug: ACT-129968|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01225315 Study 43: Title: A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancer Interventions: Drug: Ixabepilone|Drug: Doxorubicin|Drug: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT00883116 Study 44: Title: Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Neoplasms Interventions: Drug: Axitinib (AG-013736)|Drug: Sorafenib URL: http://ClinicalTrials.gov/show/NCT00920816 Study 45: Title: A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults Recruitment: Recruiting Study Results: No Results Available Conditions: Infection, Human Immunodeficiency Virus Interventions: Drug: GSK1349572|Drug: Raltegravir|Drug: GSK1349572 Placebo|Drug: Raltegravir Placebo URL: http://ClinicalTrials.gov/show/NCT01231516 Study 46: Title: A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: Drug: PegIFN/RBV|Drug: BI 201335 URL: http://ClinicalTrials.gov/show/NCT01330316 Study 47: Title: Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Multiple Sclerosis|Relapsing-remitting Interventions: Drug: AIN457|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01051817 Study 48: Title: A Study of the Efficacy and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) Recruitment: Recruiting Study Results: No Results Available Conditions: Chronic Idiopathic Urticaria Interventions: Drug: omalizumab|Drug: placebo URL: http://ClinicalTrials.gov/show/NCT01287117 Study 49: Title: Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Recruitment: Recruiting Study Results: No Results Available Conditions: Mycoses|Candidiasis, Invasive|Candidemia Interventions: Drug: Isavuconazole|Drug: Caspofungin|Drug: Voriconazole URL: http://ClinicalTrials.gov/show/NCT00413218 Study 50: Title: BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Neoplasms|Peritoneal Neoplasms Interventions: Drug: BIBF 1120|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01015118 Study 51: Title: An Immunogenicity and Pharmacokinetics (PK) Study of DAC HYP Prefilled Syringe in Relapsing Remitting Multiple Sclerosis (RRMS) Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Biological: Daclizumab High Yield Process prefilled syringe URL: http://ClinicalTrials.gov/show/NCT01462318 Study 52: Title: Study in Adolescents With Schizophrenia or Bipolar Disorder Recruitment: Recruiting Study Results: No Results Available Conditions: Bipolar I Disorder|Schizophrenia Interventions: Drug: Olanzapine|Behavioral: Standard behavioral weight intervention|Behavioral: Intense behavioral weight intervention URL: http://ClinicalTrials.gov/show/NCT00982020 Study 53: Title: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation Recruitment: Recruiting Study Results: No Results Available Conditions: Coronary Artery Disease Interventions: Drug: RVX000222|Drug: Placebo RVX000222 URL: http://ClinicalTrials.gov/show/NCT01067820 Study 54: Title: A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Drug: RO4917838|Drug: RO4917838|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01235520 Study 55: Title: Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Subjects With PHPT Unable to Undergo Parathyroidectomy Recruitment: Recruiting Study Results: No Results Available Conditions: Hyperparathyroidism, Primary Interventions: Drug: cinacalcet HCl|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00975221 Study 56: Title: Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Drug: fostamatinib|Drug: fostamatinib|Drug: placebo, fostamatinib URL: http://ClinicalTrials.gov/show/NCT01197521 Study 57: Title: Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS). Recruitment: Recruiting Study Results: No Results Available Conditions: Seizures|Epilepsy|Partial-Onset Seizures Interventions: Drug: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01336621 Study 58: Title: Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer. Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer|Metastases, Brain Interventions: Drug: capecitabine|Drug: lapatinib|Drug: trastuzumab URL: http://ClinicalTrials.gov/show/NCT00820222 Study 59: Title: STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction Recruitment: Recruiting Study Results: No Results Available Conditions: Myocardial Infarction Interventions: Drug: tenecteplase|Drug: enoxaparin|Drug: clopidogrel|Procedure: catheterisation|Procedure: primary PCI URL: http://ClinicalTrials.gov/show/NCT00623623 Study 60: Title: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Multiple Sclerosis, Relapsing-Remitting Interventions: Drug: ocrelizumab|Drug: Rebif|Drug: ocrelizumab placebo|Drug: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01247324 Study 61: Title: CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: linagliptin|Drug: glimepiride URL: http://ClinicalTrials.gov/show/NCT01243424 Study 62: Title: PANORAMA Observational Study Recruitment: Recruiting Study Results: No Results Available Conditions: Arrhythmia|Cardiac Pacemaker, Artificial|Defibrillators, Implantable Interventions: Device: Cardiac Pacemaker, Defibrillator, pacemaker lead URL: http://ClinicalTrials.gov/show/NCT00382525 Study 63: Title: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Tumor Antigen-positive Non-Small Cell Lung Cancer|Lung Cancer, Non-Small Cell Interventions: Biological: GSK1572932A Antigen-Specific Cancer Immunotherapeutic|Biological: Placebo Control URL: http://ClinicalTrials.gov/show/NCT00480025 Study 64: Title: A Study of the Quality of Life and Treatment Response to Once Weekly NeoRecormon (Epoetin Beta) Treatment in Anemic Patients With Solid and Lymphoid Malignancies. Recruitment: Recruiting Study Results: No Results Available Conditions: Anemia Interventions: Drug: epoetin beta [NeoRecormon]|Drug: epoetin beta [NeoRecormon] URL: http://ClinicalTrials.gov/show/NCT00776425 Study 65: Title: Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thromboembolism Interventions: Drug: Warfarin|Drug: Innohep® URL: http://ClinicalTrials.gov/show/NCT01130025 Study 66: Title: Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: Drug: HIV therapy URL: http://ClinicalTrials.gov/show/NCT01275625 Study 67: Title: LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Neoplasms Interventions: Drug: Afatinib 40mg once daily (OD)|Drug: Vinorelbine 25 mg/m2 weekly|Drug: Paclitaxel 80 mg/m2 weekly URL: http://ClinicalTrials.gov/show/NCT01271725 Study 68: Title: A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung) Recruitment: Not yet recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: Drug: onartuzumab [MetMAb]|Drug: erlotinib [Tarceva]|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01456325 Study 69: Title: Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Biological: ramucirumab (IMC-1121B)|Drug: docetaxel|Other: placebo URL: http://ClinicalTrials.gov/show/NCT00703326 Study 70: Title: ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing-remitting Multiple Sclerosis Interventions: Drug: ACT-128800|Drug: ACT-128800|Drug: ACT-128800 URL: http://ClinicalTrials.gov/show/NCT01093326 Study 71: Title: A Double-blind, Placebo-controlled, 2-year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease. Recruitment: Recruiting Study Results: No Results Available Conditions: Alzheimer Disease|Dementia, Alzheimer Type Interventions: Drug: Galantamine|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00679627 Study 72: Title: A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS) Recruitment: Recruiting Study Results: No Results Available Conditions: Psoriasis Interventions: Biological: ustekinumab/placebo|Biological: ustekinumab/placebo|Biological: ustekinumab/placebo URL: http://ClinicalTrials.gov/show/NCT01090427 Study 73: Title: PEARL Schizophrenia Maintenance Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Drug: Lurasidone|Drug: Matching Placebo URL: http://ClinicalTrials.gov/show/NCT01435928 Study 74: Title: Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Recruitment: Recruiting Study Results: No Results Available Conditions: Preterm Birth Interventions: Drug: Hydroxyprogesterone Caproate Injection, 250mg/mL|Drug: Vehicle URL: http://ClinicalTrials.gov/show/NCT01004029 Study 75: Title: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: aleglitazar|Drug: pioglitazone URL: http://ClinicalTrials.gov/show/NCT01043029 Study 76: Title: Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) Recruitment: Recruiting Study Results: No Results Available Conditions: Chronic Obstructive Pulmonary Disease Interventions: Drug: Roflumilast|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01329029 Study 77: Title: A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Hodgkin's Lymphoma Interventions: Drug: bendamustine|Drug: RO5072759 URL: http://ClinicalTrials.gov/show/NCT01059630 Study 78: Title: Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Drug: 2.5 mcg tiotropium Respimat|Drug: placebo Respimat|Drug: 2.5 mcg tiotropium Respimat URL: http://ClinicalTrials.gov/show/NCT01257230 Study 79: Title: TMC125IFD3002 - The VIOLIN Study: to EValuate Etravirine TolerabIlity, PharmacOkinetics With Other AntiretroviraLs In TreatmeNt Experienced Patients Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: Drug: etravirine URL: http://ClinicalTrials.gov/show/NCT01422330 Study 80: Title: Study of Paclitaxel in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer Interventions: Drug: Paclical®|Drug: Taxol® URL: http://ClinicalTrials.gov/show/NCT00989131 Study 81: Title: A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Cancer Interventions: Drug: bevacizumab [Avastin]|Drug: carboplatin|Drug: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT01239732 Study 82: Title: Asthma in Children Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: URL: http://ClinicalTrials.gov/show/NCT01286532 Study 83: Title: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Drug: rituximab [MabThera/Rituxan]|Drug: Methotrexate URL: http://ClinicalTrials.gov/show/NCT00576433 Study 84: Title: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Multiple Sclerosis, Relapsing-Remitting Interventions: Drug: ocrelizumab|Drug: Rebif|Drug: ocrelizumab placebo|Drug: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01412333 Study 85: Title: Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Recruitment: Recruiting Study Results: No Results Available Conditions: Advanced or Metastatic Non-Small Cell Lung Cancer Interventions: Drug: ABT-869|Drug: Placebo for ABT-869|Drug: ABT-869 URL: http://ClinicalTrials.gov/show/NCT00716534 Study 86: Title: Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: URL: http://ClinicalTrials.gov/show/NCT01320735 Study 87: Title: A Study of the Safety and Efficacy of CNTO 328 in Combination With Best Supportive Care Compared to Best Supportive Care in Patients With Multicentric Castleman's Disease Recruitment: Recruiting Study Results: No Results Available Conditions: Castleman's Disease Interventions: Other: Placebo|Drug: CNTO 328 URL: http://ClinicalTrials.gov/show/NCT01024036 Study 88: Title: Evaluation of SAR153191(REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Drug: SAR153191 (REGN88)|Drug: placebo URL: http://ClinicalTrials.gov/show/NCT01061736 Study 89: Title: A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Transplantation Interventions: Drug: Advagraf|Drug: Mycophenolate Mofetil|Drug: Simulect|Drug: Corticosteroids URL: http://ClinicalTrials.gov/show/NCT01304836 Study 90: Title: Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Mantle Cell Lymphoma Interventions: Drug: Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone|Drug: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone URL: http://ClinicalTrials.gov/show/NCT00722137 Study 91: Title: A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects Recruitment: Recruiting Study Results: No Results Available Conditions: DLBCL Interventions: Biological: TL011|Biological: Rituximab URL: http://ClinicalTrials.gov/show/NCT01205737 Study 92: Title: Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Drug: Sorafenib(Nexavar, BAY43-9006) / Capecitabine|Drug: Placebo / Capecitabine URL: http://ClinicalTrials.gov/show/NCT01234337 Study 93: Title: A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Recruitment: Recruiting Study Results: No Results Available Conditions: Cardiovascular Disease, Rheumatoid Arthritis Interventions: Drug: tocilizumab [RoActemra/Actemra]|Drug: etanercept URL: http://ClinicalTrials.gov/show/NCT01331837 Study 94: Title: Pregabalin Versus Levetiracetam In Partial Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Partial Seizures Interventions: Drug: pregabalin|Drug: levetiracetam URL: http://ClinicalTrials.gov/show/NCT00537238 Study 95: Title: A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis Recruitment: Recruiting Study Results: No Results Available Conditions: Parkinson's Disease Psychosis Interventions: Drug: pimavanserin tartrate (ACP-103) URL: http://ClinicalTrials.gov/show/NCT00550238 Study 96: Title: Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Recruitment: Recruiting Study Results: No Results Available Conditions: Type 2 Diabetes Mellitus Interventions: Drug: Exenatide Once Weekly|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01144338 Study 97: Title: A Study of LY2127399 in Patients With Systemic Lupus Erythematosus Recruitment: Recruiting Study Results: No Results Available Conditions: Systemic Lupus Erythematosus|Connective Tissue Disease|Autoimmune Disease Interventions: Drug: LY2127399|Drug: Placebo every 2 weeks|Drug: Placebo every 4 weeks URL: http://ClinicalTrials.gov/show/NCT01205438 Study 98: Title: Study of FP-1039 in Subjects With Endometrial Cancers Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancers With FGFR2 Mutations Interventions: Drug: FP-1039 URL: http://ClinicalTrials.gov/show/NCT01244438 Study 99: Title: TMC435HPC3007 - Phase III Trial of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: Drug: TMC435|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT01281839 Study 100: Title: Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Recruitment: Recruiting Study Results: No Results Available Conditions: Colorectal Cancer Interventions: Drug: CS-7017|Drug: Placebo URL: http://ClinicalTrials.gov/show/NCT00986440
